. 2013 Jul 2;18(7):802–811. doi: 10.1634/theoncologist.2013-0380

Table 1.

Clinicopathological data for TN tumors (n = 105) versus HR+/HER-2- tumors (n = 105) diagnosed from July 2009 through June 2011

graphic file with name onc00713-1368-t01.jpg

^aOnly the categories “Self-breast examination” and “Mammogram” were compared because of the small numbers of patients in the other groups.

^bGenetic mutations were sought in only five patients.

^cIDC associated with DCIS.

^dTumor types were 1 medullar, 2 sarcomatoid carcinoma, 3 invasive apocrine, and 1 small cell neuroendocrine.

^eGrade I: 2/2 IDC; grade II: 17/22 IDC, 5/22 DCIS.

Abbreviations: DCIS, ductal carcinoma in situ; ER, estrogen receptor; HR, hormone receptor; IDC, invasive ductal carcinoma; MRI, magnetic resonance imaging; N/A, not statistically tested because of small patient numbers; TN, triple negative.